SI9300589A - Transdermal therapeutic system for administration of fisostigmin and procedure for its preparation - Google Patents

Transdermal therapeutic system for administration of fisostigmin and procedure for its preparation Download PDF

Info

Publication number
SI9300589A
SI9300589A SI9300589A SI9300589A SI9300589A SI 9300589 A SI9300589 A SI 9300589A SI 9300589 A SI9300589 A SI 9300589A SI 9300589 A SI9300589 A SI 9300589A SI 9300589 A SI9300589 A SI 9300589A
Authority
SI
Slovenia
Prior art keywords
layer
therapeutic system
transdermal therapeutic
physostigmine
adhesive
Prior art date
Application number
SI9300589A
Other languages
English (en)
Slovenian (sl)
Inventor
Lothar Deurer
Thomas Hille
Thomas Profitlich
Fritz Stanislaus
Kersten Walter
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of SI9300589A publication Critical patent/SI9300589A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SI9300589A 1992-11-12 1993-11-11 Transdermal therapeutic system for administration of fisostigmin and procedure for its preparation SI9300589A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238223A DE4238223C1 (de) 1992-11-12 1992-11-12 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung

Publications (1)

Publication Number Publication Date
SI9300589A true SI9300589A (en) 1994-06-30

Family

ID=6472735

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300589A SI9300589A (en) 1992-11-12 1993-11-11 Transdermal therapeutic system for administration of fisostigmin and procedure for its preparation

Country Status (32)

Country Link
US (1) US5698216A (xx)
EP (1) EP0667774B1 (xx)
JP (1) JP3407073B2 (xx)
KR (1) KR100254573B1 (xx)
CN (1) CN1088457A (xx)
AT (1) ATE156356T1 (xx)
AU (1) AU684256B2 (xx)
CA (1) CA2147274C (xx)
CZ (1) CZ284008B6 (xx)
DE (2) DE4238223C1 (xx)
DK (1) DK0667774T3 (xx)
EE (1) EE03135B1 (xx)
EG (1) EG20527A (xx)
ES (1) ES2105334T3 (xx)
FI (1) FI952269A0 (xx)
GR (1) GR3024720T3 (xx)
HR (1) HRP931391B1 (xx)
HU (1) HUT72963A (xx)
IL (1) IL107547A (xx)
LT (1) LT3107B (xx)
LV (1) LV10749B (xx)
MD (1) MD937C2 (xx)
MY (1) MY111373A (xx)
NO (1) NO306760B1 (xx)
NZ (1) NZ257136A (xx)
PL (1) PL172999B1 (xx)
RU (1) RU2108812C1 (xx)
SI (1) SI9300589A (xx)
SK (1) SK280185B6 (xx)
WO (1) WO1994010999A1 (xx)
YU (1) YU71293A (xx)
ZA (1) ZA938413B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
IL72684A (en) 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
DE3843239C1 (xx) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843238C1 (xx) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
JP4355469B2 (ja) * 2002-03-08 2009-11-04 日本碍子株式会社 アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法

Also Published As

Publication number Publication date
RU2108812C1 (ru) 1998-04-20
NO951864L (no) 1995-05-11
WO1994010999A1 (de) 1994-05-26
LT3107B (en) 1994-12-27
FI952269A (fi) 1995-05-10
CA2147274C (en) 2005-12-13
KR100254573B1 (ko) 2000-05-01
GR3024720T3 (en) 1997-12-31
IL107547A (en) 1996-12-05
MD940311A (en) 1998-03-31
AU684256B2 (en) 1997-12-11
DE4238223C1 (de) 1994-05-26
IL107547A0 (en) 1994-02-27
ZA938413B (en) 1994-06-09
JPH08502986A (ja) 1996-04-02
SK59395A3 (en) 1996-05-08
MY111373A (en) 1999-12-31
ATE156356T1 (de) 1997-08-15
YU71293A (sh) 1996-07-24
CZ124495A3 (en) 1996-01-17
CA2147274A1 (en) 1994-05-26
HU9501390D0 (en) 1995-06-28
EE03135B1 (et) 1998-12-15
SK280185B6 (sk) 1999-09-10
DK0667774T3 (da) 1998-03-23
ES2105334T3 (es) 1997-10-16
LV10749B (en) 1996-06-20
MD937B2 (xx) 1998-03-31
EG20527A (en) 1999-06-30
NZ257136A (en) 1996-07-26
LTIP1469A (en) 1994-06-15
NO951864D0 (no) 1995-05-11
HUT72963A (en) 1996-06-28
NO306760B1 (no) 1999-12-20
JP3407073B2 (ja) 2003-05-19
PL308531A1 (en) 1995-08-21
HRP931391A2 (en) 1995-02-28
CN1088457A (zh) 1994-06-29
AU5338594A (en) 1994-06-08
FI952269A0 (fi) 1995-05-10
CZ284008B6 (cs) 1998-07-15
EP0667774A1 (de) 1995-08-23
DE59307089D1 (de) 1997-09-11
PL172999B1 (pl) 1998-01-30
US5698216A (en) 1997-12-16
HRP931391B1 (en) 1999-12-31
MD937C2 (ro) 1999-01-31
LV10749A (lv) 1995-08-20
KR950703948A (ko) 1995-11-17
EP0667774B1 (de) 1997-08-06

Similar Documents

Publication Publication Date Title
KR950015058B1 (ko) 활성 성분으로 피소스티그민을 함유하는 경피 치료 시스템 및 그 제조방법
KR100300477B1 (ko) 활성성분으로서 갈란타민을 포함하는 경피치료시스템
EP1225951B1 (en) A dual adhesive transdermal drug delivery system
JP3021661B2 (ja) 薬剤含有接着複合体の経皮放出デバイス
AU613814B2 (en) Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof
JPH08508266A (ja) 皮膚へのエストラジオール放出用活性物質パッチ
JPH0667835B2 (ja) 医薬組成物
SI9300387A (en) Transdermale therapeutic system containing active 17-beta estradiol (dry acid)
EP1865931A1 (en) Transdermal patch
CN112915071A (zh) 一种含有美金刚的透皮贴剂
SI9300589A (en) Transdermal therapeutic system for administration of fisostigmin and procedure for its preparation
JP3980634B2 (ja) 活性物質モルフィン−６−グルクロニドを含む全身的経皮投与用医薬組成物
EP0544900A1 (en) Transdermal nicotine absorption dosage unit and process
JP7219623B2 (ja) 経皮吸収型製剤
DK175236B1 (da) Farmaceutisk præparat
KR20020066047A (ko) 케토프로펜을 함유하는 경피투여 조성물과 이를 포함하는매트릭스형 경피투여 첩부제
JPWO2002040031A1 (ja) エストラジオール含有貼付剤
SI8912405A (sl) Postopek za izdelavo transdermalnega terapevtskega sistema z norpseudoefedrinom kot dejavno sestavino